サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1359311

世界のゴリムマブ（シンポニー）市場：実績と予測 (2018年～2029年) メーカー別、主要地域別、タイプ別、アプリケーション別の詳細データ

Global Golimumab (Simponi) Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application
出版日: | 発行: QYResearch | ページ情報: 英文 71 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界のゴリムマブ（シンポニー）市場：実績と予測 (2018年～2029年) メーカー別、主要地域別、タイプ別、アプリケーション別の詳細データ
出版日: 2023年10月12日
発行: QYResearch
ページ情報: 英文 71 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、ゴリムマブ（シンポニー） (Golimumab (Simponi)) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 ゴリムマブ（シンポニー） 市場の事業概要

  • ゴリムマブ（シンポニー） 製品概要
  • ゴリムマブ（シンポニー） 市場 セグメントタイプ別
    • 100Mg/Ml
    • 50Mg/Ml
    • 10Mg/Ml
  • 世界のゴリムマブ（シンポニー） 市場規模：タイプ別
    • 世界のゴリムマブ（シンポニー） 市場規模の事業概要 タイプ別 (2018-2029)
    • Global Golimumab (Simponi) Historic Market Size Review by Type (2018-2023)
    • Global Golimumab (Simponi) Forecasted Market Size by Type (2024-2029)
  • 主要地域別 市場規模 セグメントタイプ別
    • 北米のゴリムマブ（シンポニー） 売上 内訳 タイプ別 (2018-2023)
    • Europe Golimumab (Simponi) Sales Breakdown by Type (2018-2023)
    • Asia-Pacific Golimumab (Simponi) Sales Breakdown by Type (2018-2023)
    • Latin America Golimumab (Simponi) Sales Breakdown by Type (2018-2023)
    • Middle East and Africa Golimumab (Simponi) Sales Breakdown by Type (2018-2023)

第2章 世界のゴリムマブ（シンポニー）市場

  • 世界トップ企業 ゴリムマブ（シンポニー） 売上 (2018-2023)
  • 世界トップ企業 ゴリムマブ（シンポニー） 収益 (2018-2023)
  • 世界トップ企業 ゴリムマブ（シンポニー） 価格 (2018-2023)
  • 世界の企業 ゴリムマブ（シンポニー）の製造拠点分布, 販売地域,の製品タイプ
  • ゴリムマブ（シンポニー） 市場 競合の状況と動向
    • ゴリムマブ（シンポニー）の市場：濃度別 (2018-2023)
    • 世界の5大・10大企業 ゴリムマブ（シンポニー） 売上高と収益 in 2022
  • 世界の企業 企業タイプ別 (Tier 1, Tier 2 and Tier 3) & (売上高に基づいた in ゴリムマブ（シンポニー） (2022年時点))
  • 主要企業の参入時期 ゴリムマブ（シンポニー） 市場
  • 主要企業 ゴリムマブ（シンポニー） 取扱商品
  • M&A、事業拡大

第3章 ゴリムマブ（シンポニー） 地域別の現状と展望

  • 世界のゴリムマブ（シンポニー） 地域別市場規模および平均年間成長率: 2018 VS 2022 VS 2029
  • 世界のゴリムマブ（シンポニー）の市場規模実績：地域別
    • 世界のゴリムマブ（シンポニー） 売上：地域別 (2018-2023)
    • 世界のゴリムマブ（シンポニー） 売上：地域別 (2018-2023)
    • 世界のゴリムマブ（シンポニー） 売上 (数量と金額) 価格と売上総利益 (2018-2023)
  • 世界のゴリムマブ（シンポニー）の市場規模予測：地域別
    • 世界のゴリムマブ（シンポニー） 売上：地域別 (2024-2029)
    • 世界のゴリムマブ（シンポニー） 売上：地域別 (2024-2029)
    • 世界のゴリムマブ（シンポニー） 売上（数量・金額）価格、粗利率 (2024-2029)

第4章 世界のゴリムマブ（シンポニー） 用途別

  • ゴリムマブ（シンポニー） 市場セグメント：用途別
    • 病院
    • クリニック
    • Other
  • 世界のゴリムマブ（シンポニー） 市場規模：用途別
    • 世界のゴリムマブ（シンポニー） 市場規模概要：用途別 (2018-2029)
    • 世界のゴリムマブ（シンポニー） 市場規模の実績レビュー：用途別 (2018-2023)
    • 世界のゴリムマブ（シンポニー）の市場規模予測：用途別 (2024-2029)
  • 主要地域別 市場規模 用途別セグメント
    • 北米のゴリムマブ（シンポニー） 売上構成比：用途別 (2018-2023)
    • 欧州のゴリムマブ（シンポニー） 売上構成比：用途別 (2018-2023)
    • アジア太平洋地域 ゴリムマブ（シンポニー） 売上構成比：用途別 (2018-2023)
    • ラテンアメリカのゴリムマブ（シンポニー） 売上構成比：用途別 (2018-2023)
    • 中東・アフリカのゴリムマブ（シンポニー） 売上構成比：用途別 (2018-2023)

第5章 北米のゴリムマブ（シンポニー） 国別

  • 北米のゴリムマブ（シンポニー） 市場規模の実績：国別
    • 北米のゴリムマブ（シンポニー）の市場規模成長率 (平均年間成長率) 国別: 2018 VS 2022 VS 2029
    • 北米のゴリムマブ（シンポニー） 売上：国別 (2018-2023)
    • 北米のゴリムマブ（シンポニー） 売上：国別 (2018-2023)
  • 北米のゴリムマブ（シンポニー） 市場規模の予測：国別
    • 北米のゴリムマブ（シンポニー） 売上：国別 (2024-2029)
    • 北米のゴリムマブ（シンポニー） 売上：国別 (2024-2029)

第6章 欧州のゴリムマブ（シンポニー） 国別

  • 欧州のゴリムマブ（シンポニー） 市場規模の実績：国別
    • 欧州のゴリムマブ（シンポニー）の市場規模成長率 (平均年間成長率) 国別: 2018 VS 2022 VS 2029
    • 欧州のゴリムマブ（シンポニー） 売上：国別 (2018-2023)
    • 欧州のゴリムマブ（シンポニー） 売上：国別 (2018-2023)
  • 欧州のゴリムマブ（シンポニー） 市場規模の予測：国別
    • 欧州のゴリムマブ（シンポニー） 売上：国別 (2024-2029)
    • 欧州のゴリムマブ（シンポニー） 売上：国別 (2024-2029)

第7章 アジア太平洋地域 ゴリムマブ（シンポニー） 地域別

  • アジア太平洋地域 ゴリムマブ（シンポニー）の市場規模実績：地域別
    • アジア太平洋地域 ゴリムマブ（シンポニー）の市場規模成長率 (平均年間成長率) 地域別: 2018 VS 2022 VS 2029
    • アジア太平洋地域 ゴリムマブ（シンポニー） 売上：地域別 (2018-2023)
    • アジア太平洋地域 ゴリムマブ（シンポニー） 売上：地域別 (2018-2023)
  • アジア太平洋地域 ゴリムマブ（シンポニー）の市場規模予測：地域別
    • アジア太平洋地域 ゴリムマブ（シンポニー） 売上：地域別 (2024-2029)
    • アジア太平洋地域 ゴリムマブ（シンポニー） 売上：地域別 (2024-2029)

第8章 ラテンアメリカのゴリムマブ（シンポニー） 国別

  • ラテンアメリカのゴリムマブ（シンポニー） 市場規模の実績：国別
    • ラテンアメリカのゴリムマブ（シンポニー）の市場規模成長率 (平均年間成長率) 国別: 2018 VS 2022 VS 2029
    • ラテンアメリカのゴリムマブ（シンポニー） 売上：国別 (2018-2023)
    • ラテンアメリカのゴリムマブ（シンポニー） 売上：国別 (2018-2023)
  • ラテンアメリカのゴリムマブ（シンポニー） 市場規模の予測：国別
    • ラテンアメリカのゴリムマブ（シンポニー） 売上：国別 (2024-2029)
    • ラテンアメリカのゴリムマブ（シンポニー） 売上：国別 (2024-2029)

第9章 中東・アフリカのゴリムマブ（シンポニー） 国別

  • 中東・アフリカのゴリムマブ（シンポニー） 市場規模の実績：国別
    • 中東・アフリカのゴリムマブ（シンポニー）の市場規模成長率 (平均年間成長率) 国別: 2018 VS 2022 VS 2029
    • 中東・アフリカのゴリムマブ（シンポニー） 売上：国別 (2018-2023)
    • 中東・アフリカのゴリムマブ（シンポニー） 売上：国別 (2018-2023)
  • 中東・アフリカのゴリムマブ（シンポニー） 市場規模の予測：国別
    • 中東・アフリカのゴリムマブ（シンポニー） 売上：国別 (2024-2029)
    • 中東・アフリカのゴリムマブ（シンポニー） 売上：国別 (2024-2029)

第10章 企業プロファイル

  • Chemieliva Pharma
  • JNJ
  • DSK Biopharma
  • MSD

第11章 上流, 機会, 課題, リスクと影響要因の分析

  • ゴリムマブ（シンポニー） 主要原材料
    • 主要原材料
    • 主要原材料 価格
    • 原材料の主要サプライヤー
  • 製造コスト構造
    • 原材料
    • 人件費
    • 製造コスト
  • ゴリムマブ（シンポニー） 産業チェーン分析
  • ゴリムマブ（シンポニー） 市場動向
    • ゴリムマブ（シンポニー） 業界動向
    • ゴリムマブ（シンポニー） 市場の促進要因
    • ゴリムマブ（シンポニー） 市場の課題
    • ゴリムマブ（シンポニー） 市場の抑制要因

第12章 市場戦略分析、販売代理店

  • 販売チャネル
  • ゴリムマブ（シンポニー） 卸業者
  • ゴリムマブ（シンポニー） 下流顧客

第13章 市場調査結果と結論

第14章 付録

図表

List of Tables

  • Table 1. Major Company of 100Mg/Ml
  • Table 2. Major Company of 50Mg/Ml
  • Table 3. Major Company of 10Mg/Ml
  • Table 4. Global Golimumab (Simponi) Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Golimumab (Simponi) Sales by Type (2018-2023) & (Box)
  • Table 6. Global Golimumab (Simponi) Sales Market Share in Volume by Type (2018-2023)
  • Table 7. Global Golimumab (Simponi) Sales by Type (2018-2023) & (US& Million)
  • Table 8. Global Golimumab (Simponi) Market Share in Value by Type (2018-2023)
  • Table 9. Global Golimumab (Simponi) Price by Type (2018-2023) & (US$/Box)
  • Table 10. Global Golimumab (Simponi) Sales by Type (2024-2029) & (Box)
  • Table 11. Global Golimumab (Simponi) Sales Market Share in Volume by Type (2024-2029)
  • Table 12. Global Golimumab (Simponi) Sales by Type (2024-2029) & (US$ Million)
  • Table 13. Global Golimumab (Simponi) Sales Market Share in Value by Type (2024-2029)
  • Table 14. Global Golimumab (Simponi) Price by Type (2024-2029) & (US$/Box)
  • Table 15. North America Golimumab (Simponi) Sales by Type (2018-2023) & (Box)
  • Table 16. North America Golimumab (Simponi) Sales by Type (2018-2023) & (US$ Million)
  • Table 17. Europe Golimumab (Simponi) Sales (Box) by Type (2018-2023)
  • Table 18. Europe Golimumab (Simponi) Sales by Type (2018-2023) & (US$ Million)
  • Table 19. Asia-Pacific Golimumab (Simponi) Sales (Box) by Type (2018-2023)
  • Table 20. Asia-Pacific Golimumab (Simponi) Sales by Type (2018-2023) & (US$ Million)
  • Table 21. Latin America Golimumab (Simponi) Sales (Box) by Type (2018-2023)
  • Table 22. Latin America Golimumab (Simponi) Sales by Type (2018-2023) & (US$ Million)
  • Table 23. Middle East and Africa Golimumab (Simponi) Sales (Box) by Type (2018-2023)
  • Table 24. Middle East and Africa Golimumab (Simponi) Sales by Type (2018-2023) & (US$ Million)
  • Table 25. Global Golimumab (Simponi) Sales by Company (2018-2023) & (Box)
  • Table 26. Global Golimumab (Simponi) Sales Share by Company (2018-2023)
  • Table 27. Global Golimumab (Simponi) Revenue by Company (2018-2023) & (US$ Million)
  • Table 28. Global Golimumab (Simponi) Revenue Share by Company (2018-2023)
  • Table 29. Global Market Golimumab (Simponi) Price by Company (2018-2023) & (US$/Box)
  • Table 30. Global Golimumab (Simponi) Top Manufacturers Manufacturing Base Distribution and Sales Area
  • Table 31. Global Golimumab (Simponi) Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Golimumab (Simponi) as of 2022)
  • Table 33. Date of Key Manufacturers Enter into Golimumab (Simponi) Market
  • Table 34. Key Manufacturers Golimumab (Simponi) Product Type
  • Table 35. Mergers & Acquisitions, Expansion Plans
  • Table 36. Global Golimumab (Simponi) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. Global Golimumab (Simponi) Sales by Region (2018-2023) & (Box)
  • Table 38. Global Golimumab (Simponi) Sales Market Share in Volume by Region (2018-2023)
  • Table 39. Global Golimumab (Simponi) Sales by Region (2018-2023) & (US$ Million)
  • Table 40. Global Golimumab (Simponi) Sales Market Share in Value by Region (2018-2023)
  • Table 41. Global Golimumab (Simponi) Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2023)
  • Table 42. Global Golimumab (Simponi) Sales by Region (2024-2029) & (Box)
  • Table 43. Global Golimumab (Simponi) Sales Market Share in Volume by Region (2024-2029)
  • Table 44. Global Golimumab (Simponi) Sales by Region (2024-2029) & (US$ Million)
  • Table 45. Global Golimumab (Simponi) Sales Market Share in Value by Region (2024-2029)
  • Table 46. Global Golimumab (Simponi) Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2024-2029)
  • Table 47. Global Golimumab (Simponi) Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 48. Global Golimumab (Simponi) Sales by Application (2018-2023) & (Box)
  • Table 49. Global Golimumab (Simponi) Sales Market Share in Volume by Application (2018-2023)
  • Table 50. Global Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
  • Table 51. Global Golimumab (Simponi) Sales Market Share in Value by Application (2018-2023)
  • Table 52. Global Golimumab (Simponi) Price by Application (2018-2023) & (US$/Box)
  • Table 53. Global Golimumab (Simponi) Sales by Application (2024-2029) & (Box)
  • Table 54. Global Golimumab (Simponi) Sales Market Share in Volume by Application (2024-2029)
  • Table 55. Global Golimumab (Simponi) Sales by Application (2024-2029) & (US$ Million)
  • Table 56. Global Golimumab (Simponi) Sales Market Share in Value by Application (2024-2029)
  • Table 57. Global Golimumab (Simponi) Price by Application (2024-2029) & (US$/Box)
  • Table 58. North America Golimumab (Simponi) Sales by Application (2018-2023) (Box)
  • Table 59. North America Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
  • Table 60. Europe Golimumab (Simponi) Sales by Application (2018-2023) (Box)
  • Table 61. Europe Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
  • Table 62. Asia-Pacific Golimumab (Simponi) Sales by Application (2018-2023) (Box)
  • Table 63. Asia-Pacific Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
  • Table 64. Latin America Golimumab (Simponi) Sales by Application (2018-2023) (Box)
  • Table 65. Latin America Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
  • Table 66. Middle East and Africa Golimumab (Simponi) Sales by Application (2018-2023) (Box)
  • Table 67. Middle East and Africa Golimumab (Simponi) Sales by Application (2018-2023) & (US$ Million)
  • Table 68. North America Golimumab (Simponi) Sales by Country (2018-2023) & (Box)
  • Table 69. North America Golimumab (Simponi) Sales Market Share in Volume by Country (2018-2023)
  • Table 70. North America Golimumab (Simponi) Sales by Country (2018-2023) & (US$ Million)
  • Table 71. North America Golimumab (Simponi) Sales Market Share in Value by Country (2018-2023)
  • Table 72. North America Golimumab (Simponi) Sales by Country (2024-2029) & (Box)
  • Table 73. North America Golimumab (Simponi) Sales Market Share in Volume by Country (2024-2029)
  • Table 74. North America Golimumab (Simponi) Sales by Country (2024-2029) & (US$ Million)
  • Table 75. North America Golimumab (Simponi) Sales Market Share in Value by Country (2024-2029)
  • Table 76. Europe Golimumab (Simponi) Sales by Country (2018-2023) & (Box)
  • Table 77. Europe Golimumab (Simponi) Sales Market Share in Volume by Country (2018-2023)
  • Table 78. Europe Golimumab (Simponi) Sales by Country (2018-2023) & (US$ Million)
  • Table 79. Europe Golimumab (Simponi) Sales Market Share in Value by Country (2018-2023)
  • Table 80. Europe Golimumab (Simponi) Sales by Country (2024-2029) & (Box)
  • Table 81. Europe Golimumab (Simponi) Sales Market Share in Volume by Country (2024-2029)
  • Table 82. Europe Golimumab (Simponi) Sales by Country (2024-2029) & (US$ Million)
  • Table 83. Europe Golimumab (Simponi) Sales Market Share in Value by Country (2024-2029)
  • Table 84. Asia-Pacific Golimumab (Simponi) Sales by Region (2018-2023) & (Box)
  • Table 85. Asia-Pacific Golimumab (Simponi) Sales Market Share in Volume by Region (2018-2023)
  • Table 86. Asia-Pacific Golimumab (Simponi) Sales by Region (2018-2023) & (US$ Million)
  • Table 87. Asia-Pacific Golimumab (Simponi) Sales Market Share in Value by Region (2018-2023)
  • Table 88. Asia-Pacific Golimumab (Simponi) Sales by Region (2024-2029) & (Box)
  • Table 89. Asia-Pacific Golimumab (Simponi) Sales Market Share in Volume by Region (2024-2029)
  • Table 90. Asia-Pacific Golimumab (Simponi) Sales by Region (2024-2029) & (US$ Million)
  • Table 91. Asia-Pacific Golimumab (Simponi) Sales Market Share in Value by Region (2024-2029)
  • Table 92. Latin America Golimumab (Simponi) Sales by Country (2018-2023) & (Box)
  • Table 93. Latin America Golimumab (Simponi) Sales Market Share in Volume by Country (2018-2023)
  • Table 94. Latin America Golimumab (Simponi) Sales by Country (2018-2023) & (US$ Million)
  • Table 95. Latin America Golimumab (Simponi) Sales Market Share in Value by Country (2018-2023)
  • Table 96. Latin America Golimumab (Simponi) Sales by Country (2024-2029) & (Box)
  • Table 97. Latin America Golimumab (Simponi) Sales Market Share in Volume by Country (2024-2029)
  • Table 98. Latin America Golimumab (Simponi) Sales by Country (2024-2029) & (US$ Million)
  • Table 99. Latin America Golimumab (Simponi) Sales Market Share in Value by Country (2024-2029)
  • Table 100. Middle East and Africa Golimumab (Simponi) Sales by Country (2018-2023) & (Box)
  • Table 101. Middle East and Africa Golimumab (Simponi) Sales Market Share in Volume by Country (2018-2023)
  • Table 102. Middle East and Africa Golimumab (Simponi) Sales by Country (2018-2023) & (US$ Million)
  • Table 103. Middle East and Africa Golimumab (Simponi) Sales Market Share in Value by Country (2018-2023)
  • Table 104. Middle East and Africa Golimumab (Simponi) Sales by Country (2024-2029) & (Box)
  • Table 105. Middle East and Africa Golimumab (Simponi) Sales Market Share in Volume by Country (2024-2029)
  • Table 106. Middle East and Africa Golimumab (Simponi) Sales by Country (2024-2029) & (US$ Million)
  • Table 107. Middle East and Africa Golimumab (Simponi) Sales Market Share in Value by Country (2024-2029)
  • Table 108. Chemieliva Pharma Company Information
  • Table 109. Chemieliva Pharma Introduction and Business Overview
  • Table 110. Chemieliva Pharma Golimumab (Simponi) Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2023)
  • Table 111. Chemieliva Pharma Golimumab (Simponi) Product
  • Table 112. Chemieliva Pharma Recent Development
  • Table 113. JNJ Company Information
  • Table 114. JNJ Introduction and Business Overview
  • Table 115. JNJ Golimumab (Simponi) Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2023)
  • Table 116. JNJ Golimumab (Simponi) Product
  • Table 117. JNJ Recent Development
  • Table 118. DSK Biopharma Company Information
  • Table 119. DSK Biopharma Introduction and Business Overview
  • Table 120. DSK Biopharma Golimumab (Simponi) Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2023)
  • Table 121. DSK Biopharma Golimumab (Simponi) Product
  • Table 122. DSK Biopharma Recent Development
  • Table 123. MSD Company Information
  • Table 124. MSD Introduction and Business Overview
  • Table 125. MSD Golimumab (Simponi) Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2023)
  • Table 126. MSD Golimumab (Simponi) Product
  • Table 127. MSD Recent Development
  • Table 128. Key Raw Materials Lists
  • Table 129. Raw Materials Key Suppliers Lists
  • Table 130. Golimumab (Simponi) Market Trends
  • Table 131. Golimumab (Simponi) Market Drivers
  • Table 132. Golimumab (Simponi) Market Challenges
  • Table 133. Golimumab (Simponi) Market Restraints
  • Table 134. Golimumab (Simponi) Distributors List
  • Table 135. Golimumab (Simponi) Downstream Customers
  • Table 136. Research Programs/Design for This Report
  • Table 137. Key Data Information from Secondary Sources
  • Table 138. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Golimumab (Simponi) Product Picture
  • Figure 2. Global Golimumab (Simponi) Market Size, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Golimumab (Simponi) Market Size Status and Outlook (2018-2029) & (US$ Million)
  • Figure 4. Global Golimumab (Simponi) Sales Status and Outlook (2018-2029) & (Box)
  • Figure 5. Product Picture of 100Mg/Ml
  • Figure 6. Global 100Mg/Ml Sales YoY Growth (2018-2029) & (Box)
  • Figure 7. Product Picture of 50Mg/Ml
  • Figure 8. Global 50Mg/Ml Sales YoY Growth (2018-2029) & (Box)
  • Figure 9. Product Picture of 10Mg/Ml
  • Figure 10. Global 10Mg/Ml Sales YoY Growth (2018-2029) & (Box)
  • Figure 11. Global Golimumab (Simponi) Sales by Type (2018-2029) & (US$ Million)
  • Figure 12. Global Golimumab (Simponi) Sales Market Share by Type in 2022 & 2029
  • Figure 13. North America Golimumab (Simponi) Sales Market Share in Volume by Type in 2022
  • Figure 14. North America Golimumab (Simponi) Sales Market Share in Value by Type in 2022
  • Figure 15. Europe Golimumab (Simponi) Sales Market Share in Volume by Type in 2022
  • Figure 16. Europe Golimumab (Simponi) Sales Market Share in Value by Type in 2022
  • Figure 17. Asia-Pacific Golimumab (Simponi) Sales Market Share in Volume by Type in 2022
  • Figure 18. Asia-Pacific Golimumab (Simponi) Sales Market Share in Value by Type in 2022
  • Figure 19. Latin America Golimumab (Simponi) Sales Market Share in Volume by Type in 2022
  • Figure 20. Latin America Golimumab (Simponi) Sales Market Share in Value by Type in 2022
  • Figure 21. Middle East and Africa Golimumab (Simponi) Sales Market Share in Volume by Type in 2022
  • Figure 22. Middle East and Africa Golimumab (Simponi) Sales Market Share in Value by Type in 2022
  • Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Golimumab (Simponi) Sales in 2022
  • Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Golimumab (Simponi) Revenue in 2022
  • Figure 25. Golimumab (Simponi) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 26. Product Picture of Hospital
  • Figure 27. Global Hospital Sales YoY Growth (2018-2029) & (Box)
  • Figure 28. Product Picture of Clinic
  • Figure 29. Global Clinic Sales YoY Growth (2018-2029) & (Box)
  • Figure 30. Product Picture of Other
  • Figure 31. Global Other Sales YoY Growth (2018-2029) & (Box)
  • Figure 32. Global Golimumab (Simponi) Sales by Application (2018-2029) & (US$ Million)
  • Figure 33. Global Golimumab (Simponi) Sales Market Share by Application in 2022 & 2029
  • Figure 34. North America Golimumab (Simponi) Sales Market Share in Volume by Application in 2022
  • Figure 35. North America Golimumab (Simponi) Sales Market Share in Value by Application in 2022
  • Figure 36. Europe Golimumab (Simponi) Sales Market Share in Volume by Application in 2022
  • Figure 37. Europe Golimumab (Simponi) Sales Market Share in Value by Application in 2022
  • Figure 38. Asia-Pacific Golimumab (Simponi) Sales Market Share in Volume by Application in 2022
  • Figure 39. Asia-Pacific Golimumab (Simponi) Sales Market Share in Value by Application in 2022
  • Figure 40. Latin America Golimumab (Simponi) Sales Market Share in Volume by Application in 2022
  • Figure 41. Latin America Golimumab (Simponi) Sales Market Share in Value by Application in 2022
  • Figure 42. Middle East and Africa Golimumab (Simponi) Sales Market Share in Value by Application in 2022
  • Figure 43. Key Raw Materials Price
  • Figure 44. Golimumab (Simponi) Manufacturing Cost Structure
  • Figure 45. Golimumab (Simponi) Industrial Chain Analysis
  • Figure 46. Channels of Distribution
  • Figure 47. Distributors Profiles
  • Figure 48. Bottom-up and Top-down Approaches for This Report
  • Figure 49. Data Triangulation
  • Figure 50. Key Executives Interviewed
目次

This research report focuses on the Golimumab (Simponi) Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Golimumab (Simponi) Market Overview

  • 1.1 Golimumab (Simponi) Product Overview
  • 1.2 Golimumab (Simponi) Market Segment by Type
    • 1.2.1 100Mg/Ml
    • 1.2.2 50Mg/Ml
    • 1.2.3 10Mg/Ml
  • 1.3 Global Golimumab (Simponi) Market Size by Type
    • 1.3.1 Global Golimumab (Simponi) Market Size Overview by Type (2018-2029)
    • 1.3.2 Global Golimumab (Simponi) Historic Market Size Review by Type (2018-2023)
    • 1.3.3 Global Golimumab (Simponi) Forecasted Market Size by Type (2024-2029)
  • 1.4 Key Regions Market Size Segment by Type
    • 1.4.1 North America Golimumab (Simponi) Sales Breakdown by Type (2018-2023)
    • 1.4.2 Europe Golimumab (Simponi) Sales Breakdown by Type (2018-2023)
    • 1.4.3 Asia-Pacific Golimumab (Simponi) Sales Breakdown by Type (2018-2023)
    • 1.4.4 Latin America Golimumab (Simponi) Sales Breakdown by Type (2018-2023)
    • 1.4.5 Middle East and Africa Golimumab (Simponi) Sales Breakdown by Type (2018-2023)

2 Global Golimumab (Simponi) Market Competition by Company

  • 2.1 Global Top Players by Golimumab (Simponi) Sales (2018-2023)
  • 2.2 Global Top Players by Golimumab (Simponi) Revenue (2018-2023)
  • 2.3 Global Top Players by Golimumab (Simponi) Price (2018-2023)
  • 2.4 Global Top Manufacturers Golimumab (Simponi) Manufacturing Base Distribution, Sales Area, Product Type
  • 2.5 Golimumab (Simponi) Market Competitive Situation and Trends
    • 2.5.1 Golimumab (Simponi) Market Concentration Rate (2018-2023)
    • 2.5.2 Global 5 and 10 Largest Manufacturers by Golimumab (Simponi) Sales and Revenue in 2022
  • 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Golimumab (Simponi) as of 2022)
  • 2.7 Date of Key Manufacturers Enter into Golimumab (Simponi) Market
  • 2.8 Key Manufacturers Golimumab (Simponi) Product Offered
  • 2.9 Mergers & Acquisitions, Expansion

3 Golimumab (Simponi) Status and Outlook by Region

  • 3.1 Global Golimumab (Simponi) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
  • 3.2 Global Golimumab (Simponi) Historic Market Size by Region
    • 3.2.1 Global Golimumab (Simponi) Sales in Volume by Region (2018-2023)
    • 3.2.2 Global Golimumab (Simponi) Sales in Value by Region (2018-2023)
    • 3.2.3 Global Golimumab (Simponi) Sales (Volume & Value) Price and Gross Margin (2018-2023)
  • 3.3 Global Golimumab (Simponi) Forecasted Market Size by Region
    • 3.3.1 Global Golimumab (Simponi) Sales in Volume by Region (2024-2029)
    • 3.3.2 Global Golimumab (Simponi) Sales in Value by Region (2024-2029)
    • 3.3.3 Global Golimumab (Simponi) Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Golimumab (Simponi) by Application

  • 4.1 Golimumab (Simponi) Market Segment by Application
    • 4.1.1 Hospital
    • 4.1.2 Clinic
    • 4.1.3 Other
  • 4.2 Global Golimumab (Simponi) Market Size by Application
    • 4.2.1 Global Golimumab (Simponi) Market Size Overview by Application (2018-2029)
    • 4.2.2 Global Golimumab (Simponi) Historic Market Size Review by Application (2018-2023)
    • 4.2.3 Global Golimumab (Simponi) Forecasted Market Size by Application (2024-2029)
  • 4.3 Key Regions Market Size Segment by Application
    • 4.3.1 North America Golimumab (Simponi) Sales Breakdown by Application (2018-2023)
    • 4.3.2 Europe Golimumab (Simponi) Sales Breakdown by Application (2018-2023)
    • 4.3.3 Asia-Pacific Golimumab (Simponi) Sales Breakdown by Application (2018-2023)
    • 4.3.4 Latin America Golimumab (Simponi) Sales Breakdown by Application (2018-2023)
    • 4.3.5 Middle East and Africa Golimumab (Simponi) Sales Breakdown by Application (2018-2023)

5 North America Golimumab (Simponi) by Country

  • 5.1 North America Golimumab (Simponi) Historic Market Size by Country
    • 5.1.1 North America Golimumab (Simponi) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 5.1.2 North America Golimumab (Simponi) Sales in Volume by Country (2018-2023)
    • 5.1.3 North America Golimumab (Simponi) Sales in Value by Country (2018-2023)
  • 5.2 North America Golimumab (Simponi) Forecasted Market Size by Country
    • 5.2.1 North America Golimumab (Simponi) Sales in Volume by Country (2024-2029)
    • 5.2.2 North America Golimumab (Simponi) Sales in Value by Country (2024-2029)

6 Europe Golimumab (Simponi) by Country

  • 6.1 Europe Golimumab (Simponi) Historic Market Size by Country
    • 6.1.1 Europe Golimumab (Simponi) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 6.1.2 Europe Golimumab (Simponi) Sales in Volume by Country (2018-2023)
    • 6.1.3 Europe Golimumab (Simponi) Sales in Value by Country (2018-2023)
  • 6.2 Europe Golimumab (Simponi) Forecasted Market Size by Country
    • 6.2.1 Europe Golimumab (Simponi) Sales in Volume by Country (2024-2029)
    • 6.2.2 Europe Golimumab (Simponi) Sales in Value by Country (2024-2029)

7 Asia-Pacific Golimumab (Simponi) by Region

  • 7.1 Asia-Pacific Golimumab (Simponi) Historic Market Size by Region
    • 7.1.1 Asia-Pacific Golimumab (Simponi) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
    • 7.1.2 Asia-Pacific Golimumab (Simponi) Sales in Volume by Region (2018-2023)
    • 7.1.3 Asia-Pacific Golimumab (Simponi) Sales in Value by Region (2018-2023)
  • 7.2 Asia-Pacific Golimumab (Simponi) Forecasted Market Size by Region
    • 7.2.1 Asia-Pacific Golimumab (Simponi) Sales in Volume by Region (2024-2029)
    • 7.2.2 Asia-Pacific Golimumab (Simponi) Sales in Value by Region (2024-2029)

8 Latin America Golimumab (Simponi) by Country

  • 8.1 Latin America Golimumab (Simponi) Historic Market Size by Country
    • 8.1.1 Latin America Golimumab (Simponi) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 8.1.2 Latin America Golimumab (Simponi) Sales in Volume by Country (2018-2023)
    • 8.1.3 Latin America Golimumab (Simponi) Sales in Value by Country (2018-2023)
  • 8.2 Latin America Golimumab (Simponi) Forecasted Market Size by Country
    • 8.2.1 Latin America Golimumab (Simponi) Sales in Volume by Country (2024-2029)
    • 8.2.2 Latin America Golimumab (Simponi) Sales in Value by Country (2024-2029)

9 Middle East and Africa Golimumab (Simponi) by Country

  • 9.1 Middle East and Africa Golimumab (Simponi) Historic Market Size by Country
    • 9.1.1 Middle East and Africa Golimumab (Simponi) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 9.1.2 Middle East and Africa Golimumab (Simponi) Sales in Volume by Country (2018-2023)
    • 9.1.3 Middle East and Africa Golimumab (Simponi) Sales in Value by Country (2018-2023)
  • 9.2 Middle East and Africa Golimumab (Simponi) Forecasted Market Size by Country
    • 9.2.1 Middle East and Africa Golimumab (Simponi) Sales in Volume by Country (2024-2029)
    • 9.2.2 Middle East and Africa Golimumab (Simponi) Sales in Value by Country (2024-2029)

10 Company Profiles

  • 10.1 Chemieliva Pharma
    • 10.1.1 Chemieliva Pharma Company Information
    • 10.1.2 Chemieliva Pharma Introduction and Business Overview
    • 10.1.3 Chemieliva Pharma Golimumab (Simponi) Sales, Revenue and Gross Margin (2018-2023)
    • 10.1.4 Chemieliva Pharma Golimumab (Simponi) Products Offered
    • 10.1.5 Chemieliva Pharma Recent Development
  • 10.2 JNJ
    • 10.2.1 JNJ Company Information
    • 10.2.2 JNJ Introduction and Business Overview
    • 10.2.3 JNJ Golimumab (Simponi) Sales, Revenue and Gross Margin (2018-2023)
    • 10.2.4 JNJ Golimumab (Simponi) Products Offered
    • 10.2.5 JNJ Recent Development
  • 10.3 DSK Biopharma
    • 10.3.1 DSK Biopharma Company Information
    • 10.3.2 DSK Biopharma Introduction and Business Overview
    • 10.3.3 DSK Biopharma Golimumab (Simponi) Sales, Revenue and Gross Margin (2018-2023)
    • 10.3.4 DSK Biopharma Golimumab (Simponi) Products Offered
    • 10.3.5 DSK Biopharma Recent Development
  • 10.4 MSD
    • 10.4.1 MSD Company Information
    • 10.4.2 MSD Introduction and Business Overview
    • 10.4.3 MSD Golimumab (Simponi) Sales, Revenue and Gross Margin (2018-2023)
    • 10.4.4 MSD Golimumab (Simponi) Products Offered
    • 10.4.5 MSD Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

  • 11.1 Golimumab (Simponi) Key Raw Materials
    • 11.1.1 Key Raw Materials
    • 11.1.2 Key Raw Materials Price
    • 11.1.3 Raw Materials Key Suppliers
  • 11.2 Manufacturing Cost Structure
    • 11.2.1 Raw Materials
    • 11.2.2 Labor Cost
    • 11.2.3 Manufacturing Expenses
  • 11.3 Golimumab (Simponi) Industrial Chain Analysis
  • 11.4 Golimumab (Simponi) Market Dynamics
    • 11.4.1 Golimumab (Simponi) Industry Trends
    • 11.4.2 Golimumab (Simponi) Market Drivers
    • 11.4.3 Golimumab (Simponi) Market Challenges
    • 11.4.4 Golimumab (Simponi) Market Restraints

12 Market Strategy Analysis, Distributors

  • 12.1 Sales Channel
  • 12.2 Golimumab (Simponi) Distributors
  • 12.3 Golimumab (Simponi) Downstream Customers

13 Research Findings and Conclusion

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 Author Details
  • 14.3 Disclaimer